FAETH THERAPEUTICS INC

Faeth Therapeutics dips 1.06% to $20.10, with a $531.5M market cap and 24‑hour volume of $3.8M. Explore its clinical‑stage immunotherapy focus, key metrics, and peer performance.

Faeth Therapeutics shares jump 3.4% as the company teases preclinical PIKTOR data for breast cancer, promising new multi‑node therapy insights.